In Vivo Stem Cell Extraction Device

The need for controlled medical tissue regeneration for use in trauma or disease therapies has long existed. Only recently, however, has sufficient technology been developed to even begin exploring potential human applications. A key breakthrough was the discovery of the stem cell as a significant element for regeneration. Yet, in order for stem cells to be of medical use, cells of the similar (allogeneic) type as the patient are needed preferably from the patient herself (autologous). Moreover, sufficient numbers of stem cells need to be made available. This is especially difficult in trauma patients where little time is given to prepare for sufficient autologous stem cell harvest. Our proposed research will build upon CellTraffix established technology for the capture of functioning circulating stem cells from the blood. We propose a plan that will work towards: 1. Scalable increase of our technology into a device that will harvest a sufficient number of stem cells for clinical regenerative purposes (without the need for ex vivo expansion) 2. Safe, implantable, and removable interface with the patient 3. Development of the technology towards commercial use in the private sector, government application, and multi-national healthcare industries